Please assess the completion status of the following clinical trial:

Trial Title: Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated Ventricular Tachycardia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with stable tachycardia ≥120 lpm, QRS ≥120 ms and haemodynamically well tolerated defined as: 1)Systolic blood pressure ≥90 mmHg, 2) absence of dyspnea at rest, 3)absence of peripheric hypoperfusion signs and 4)no severe angina.~* Age \> 18 years~* Written inform consent obtained~Exclusion Criteria:~* Treatment with iv amiodarone or iv procainamide during the previous 24 hours~* QRS tachycardia \<120 ms~* Patients with QRS ≥120 ms tachycardia with haemodynamic compromise that requires urgent cardioversion for termination~* Irregular tachycardia~* Tachycardia that is considered as supraventricular due to physician criteria (adenosine and/or vagal manoeuvres response)~* Patient that do not want to cooperate

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: ACTIVE_COMPARATOR): IV procainamide (single dose: 10 mg/kg over 20 min)
- Group 2 (Type: ACTIVE_COMPARATOR): IV Amiodarone (single dose: 5 mg/kg over 20 min)

Based on this trial design, predict the completion outcome and termination type (if applicable).